FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.
Echocardiography is a vital first-line imaging tool for the diagnosis and management of many cardiovascular diseases. Its availability and low cost have encouraged widespread use…
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.
BACKGROUND: While tricuspid annular plane systolic excursion (TAPSE) captures the predominant longitudinal motion of the right ventricle (RV), it does not account for ventricular morphology…
Several surgeons told TCTMD they’re highly critical of the trend, saying it’s time for an RCT of TAVI vs SAVR in those below age 65.
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions to the care…
May 6, 2024—Medtronic announced it received approval from the National Medical Products Administration (NMPA) in China for its Symplicity Spyral
The U.S. Food and Drug Administration (FDA) announced on May 1 that the Apple Atrial Fibrillation (AFib) History Feature now qualifies as a Medical Device…
MedAxiom is the cardiovascular community’s premier source for organizational performance solutions.